2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide

DB04310ExperimentalSmall molecule

2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide: Overview.

Mechanism: Pharmacologically active on Peptide deformylase
Curator reviewed
Formula / weight: C₁₉H₃₅N₃O₅ · 385.4983 g/mol (avg)

Resolves to

Compound

UNIIP18SPA8N0KCAS13434-13-4ChEMBLCHEMBL308333PubChem443600KEGGC12056

Structure

InChIKeyXJLATMLVMSFZBN-VYDXJSESSA-NSMILES[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO

Targets

P68826defQ93LE9defQ819U0def1Q819K2def2Q82ZJ0defP68771defQ9HBH1PDFQ9I7A8def+3 more

What you can answer from here — as of August 31, 2026

11Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account